China Pharma Holdings, Inc. (OTC BB: CPHI), China Pharma Holdings, Inc. is a specialty pharmaceutical manufacturer based in Haikou City, Hainan province. The company develops, manufactures, and markets both Western and Chinese generic and brand biopharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, vascular, CNS and other prevailing diseases. The company has scalable GMP certified manufacturing facilities, a strong R&D platform supported by relationships with multiple universities, a broad portfolio of products and a pipeline of nine products in different stages of the approval process.